Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 Morrison Briggs Director Grant or award · Stock Option (Right to Buy) +13,000 13,000
2026-06-05 Rommel Christian Director Grant or award · Stock Option (Right to Buy) +13,000 13,000
2026-06-05 Treco Douglas A Director Grant or award · Stock Option (Right to Buy) +13,000 13,000
2026-05-29 KASINGER JAMES R. General Counsel and Secretary Grant or award · Restricted Stock Units +17,000 17,000
2026-05-29 Patel Naimish Chief Medical Officer Grant or award · Restricted Stock Units +22,000 22,000
2026-05-29 Prasad Raju Chief Financial Officer Grant or award · Restricted Stock Units +19,500 19,500
2026-05-29 Patel Naimish Chief Medical Officer Sale −3,786 $55.62 $211K 19,357
2026-05-28 Patel Naimish Chief Medical Officer Option exercise +10,000 23,143
2026-05-28 Patel Naimish Chief Medical Officer Option exercise · Restricted Stock Units −10,000 20,000
2026-03-23 KASINGER JAMES R. General Counsel and Secretary Sale −3,182 $46.78 $149K 94,308
2026-03-23 Kulkarni Samarth Chief Executive Officer Sale −10,020 $46.78 $469K 255,501
2026-03-23 Prasad Raju Chief Financial Officer Sale −3,708 $46.78 $173K 15,565
2026-03-20 KASINGER JAMES R. General Counsel and Secretary Option exercise +6,250 97,490
2026-03-20 KASINGER JAMES R. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +38,499 38,499
2026-03-20 KASINGER JAMES R. General Counsel and Secretary Grant or award · Restricted Stock Units +25,000 25,000
2026-03-20 KASINGER JAMES R. General Counsel and Secretary Option exercise · Restricted Stock Units −6,250 12,000
2026-03-20 Kulkarni Samarth Chief Executive Officer Option exercise +19,687 265,521
2026-03-20 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) +114,249 114,249
2026-03-20 Kulkarni Samarth Chief Executive Officer Grant or award · Restricted Stock Units +81,875 81,875
2026-03-20 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units −19,687 39,375

Page 3 of 46 · 910 trades